Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

The latest addition to the market research report database of Transparency Market Research is a report on the dynamic Life Sciences BPO market. The new report-titled Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019-analyzes the core factors influencing this market and potential growth areas as well as restraints besides profiling leading market players in this sector.

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1782

According to the report, the global market for Life Sciences business process outsourcing (BPO) was worth USD 152.5 billion in 2012, and expert analysts from the firm predict through in-depth analyses that the market will likely be worth USD 596.0 billion by 2019, demonstrating a healthy compounded annual growth rate (CAGR) of 21.5% between 2013 and 2019.

In the recent years, several factors have collectively contributed towards creating a need for Life Sciences BPO. Among these are the increasingly complex rules that govern clinical trials, growing pressure from regulatory bodies, as well as the pressure of rising cost of inputs and R&D.

This has compelled market players to look at various alternative means that can help curtail costs without compromising their competitive edge in the market. Many players regard outsourcing as an efficient answer to these concerns, creating a burgeoning market for Life Sciences BPO services worldwide. This market has risen significantly over the past decade and there has been growing acceptance of Life Sciences BPO providers.

Furthermore, leading companies in the life sciences sector have also had to deal with patent expirations that have risen in numbers over the last few years. Not to mention the costs associated with the failure of certain drugs and products at the clinical trials stage. These are a few other factors that have spurred a demand for Life Sciences BPO services, or the pharmaceutical outsourcing services-as some refer to it.

According to the market research report that is based on data obtained from key industry players, a number of pharmaceutical and biotech firms regard outsourcing certain activities as a solution to helping these companies focus on their strategic and core functions. These companies can then engage their highly skilled resources in more productive strategies and cutting-edge projects in-house.

The market research report by Transparency Market Research discusses the existing as well as expected market share of the various segments within the Life Sciences BPO market such as the Contract Manufacturing Organizations (CMOs), which is the largest segment by size, and the Contract Research Organizations (CROs).

Furthermore, this in-depth research report also discusses the various factors that have directly or indirectly stirred a demand for generic drugs and consequently, a demand for outsourced activities as well. It also throws light on the various advantages experienced by market players via their outsourcing partners on the R&D, compliance, marketing, and productivity front. Within the CMO market, the market for API constitutes the largest segment.

Similarly, the services of CROs are regarded as being crucial to the life sciences and pharmaceutical segments in the contemporary scenario because of a myriad of factors. The report by Transparency Market Research discusses the various propellants that have led to these services being sought after (including factors such as rising costs of clinical trials, marketing costs, compliance complexities, and so on). Within the CRO market, the largest segment was that of drug discovery.

Based on various analyses, the report also anticipates that the market for clinical data management services outsourcing is likely to witness the highest rate of growth, pegged at 17.3%, between 2013 and 2019.

The market research report then goes on to dissect the global Life Sciences BPO market based on geography, by market share as well as revenue. It predicts that the highest growth within this sector will be observed in the Asia-Pacific region over the forecast period, owing to a number of favorable factors.

Browse Life Sciences BPO Market Research Report With Full TOC @ http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Global Pharmacovigilance Market Will Reach USD 5.0 Billion in 2019 : Transparency Market Research

Transparency Market Research “Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,“ the global pharmacovigilance market was valued at USD 2,147.3 million in 2012 and is estimated to reach a market worth USD 5,008.2 million in 2019 at a CAGR of 12.9% from 2013 to 2019.

Browse Global Pharmacovigilance Market Report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilance-market.html

Rising regulatory concerns, public safety issues, tough inspection regime coupled with instant need of patient reporting has provided the much needed impetus for the pharmacovigilance market. According to World Health Organization (WHO) the pharmacovigilance is defined as the science and activities involved in the detection, assessment, monitoring and evaluation of adverse events or any drug related problems of the medicinal products. The main objective of pharmacovigilance is the safer administration of medicinal products, which is attained through awareness of precise, timely and relevant clinical safety information of medical products.

The rapid growth of global pharmaceutical industry has resulted in the innovation in the number of medicinal products that can Transparency Market Researchtreat, cure and prevent various disorders. Although, the newly developed products have various benefits, these are allied with number of adverse drug events that can range from mild to severe side effects often resulting in disabilities, illness and death. In order to evade this, early detection of the adverse drug reactions in clinical trials and active clinical phase IV or post-marketing surveillance is imperative to identify these adverse events associate with the products. Nowadays, all the pharmaceutical companies are actively involved in the safety assessment and monitoring of medicinal products which are under clinical trials and also for marketed products. Until recently, the scope of the drug safety reporting was restricted to assessment and monitoring of very small number of medicinal products but now it has been extended to various products such as medical devices, traditional medicines, blood products, vaccines, etc.

The guidelines for the appropriate implementation of drug safety reporting services has been formulated by various national and international regulatory authorities such as the World Health Organization (WHO) and United States Food and Drug Administration (USFDA) are aiding in enhancement of the overall PV activities being conducted by the pharmaceutical companies

The global market for pharmacovigilance services is segmented based on type of clinical trial phases, service providers and methods used in drug safety reporting. Based on type of clinical trial phases, the market is categorized in to preclinical studies, phase I, II, III, IV or post-marketing surveillance services market. Among these, the market for clinical trial phase IV drug safety reporting services market accounts for the largest market share of 74.7% in 2012 and was valued to USD 1,604.8 million in the same year .

This market is expected to lead the pharmacovigilance market till 2019 owing to rise in public safety issues coupled with growing regulatory concerns regarding safety of the marketed products. In addition, the market is segmented based on type of service providers by in-house and contract outsourcing services market. Among these, contract outsourcing pharmacovigilance services market accounts for the largest market share of 50.8% in 2012 and is forecast to grow at a healthy growth rate of 15.5% during the forecast period of 2013 to 2019. The contributing factors behind such an assessment include its high cost involvement, quality concerns, requirement of highly qualified professionals and growing regulatory concerns.

Geographically, the North American region constituted the largest market for global pharmacovigilance market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 15.2% from 2013 to 2019. This growth has been attributed to large population base, low healthcare cost and high enrolment rate of patients. In addition, favorable government support, growing pharmaceutical industry would trigger the growth of this market in Asian-Pacific region.

The leading market players include Accenture, Plc, Bristol-Myers Squibb, Covance, Inc., Cognizant Technology Solutions, Icon, Plc.,iGATE Corporation, Novartis International AG, Parexel International Corporation, PRA International, Inc., Pharmaceutical Product Development, Inc. (PPD), Pfizer, Inc., Quintiles Transnational Corporation and Wipro Limited.

The global pharmacovigilance market is segmented as follows:

Global Pharmacovigilance Market, by Segments

Pharmacovigilance Market
Type of clinical trial phases
Pre-Clinical Studies
Phase I
Phase II
Phase III
Phase IV or Post-marketing Surveillance
Type of service providers
In-House
Contract Outsourcing
Type of methods used in drug safety reporting
Spontaneous reporting
Intensified ADR reporting
Targeted reporting
Cohort event monitoring
EHR monitoring
Global Life Sciences BPO Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (ROW)

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1729

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Regenerative Medicine (Bone and Joint) Market Expected to Reach USD 6.5 Billion Globally in 2019

According to a new market research report published by Transparency Market Research “Regenerative Medicine (Bone and Joint) Market (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019” the global regenerative medicine (bone and joint) market was valued at USD 2.6 billion in 2012 and is estimated to reach a market worth of USD 6.5 billion in 2019 growing at a CAGR of 12.8% from 2013 to 2019.

Browse the full Regenerative Medicine Market Report at http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint) market. However, ethical issues pertaining to stem cell therapy and fear of disease transmission due to allogeneic bone implantation are considered as market hindering factors during the study period. Companies operating in this market focus on investing in emerging economies of Asia-Pacific such as India, China, Japan and South Korea. These economies represent huge potential for various bone and joint reconstructive products due to rising healthcare expenditure and presence of large patient pool suffering from arthritis disorder (rheumatoid arthritis).

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. However, high cost associated with biomaterials is a factor that would restrict the global market demand to some extent during the study period.

In addition, based on applications the global market for regenerative medicine (bone and joint) is segmented as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. However, post implantation rejection associated with bone graft substitute is considered as a crucial factor that would restrict the global market demand of bone graft substitute.

Browse the Press Release of Regenerative Medicine Market @ http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.html

On the basis of geography, the regenerative medicine (bone and joint) market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America accounted for the largest market share for regenerative medicine (bone and joint) globally in 2012 owing to increase in orthopedic reconstructive surgeries and introduction of technologically advanced medical devices and products. According to the American Academy of Orthopedic Surgeons (AAOS), prevalence of Lumbar Spinal Stenosis (LSS) is increasing with rise in elderly population and is estimated that approximately 2.4 million Americans would be affected by LSS by 2021. It has also stated that in 1990 approximately 129,000 Total Knee Arthroplasty (TKA) surgeries were performed in the U.S.

Europe accounted for the second largest share in the global regenerative medicine (bone and joint) market in 2012. Large geriatric population base is one of the important factors driving the growth of regenerative medicine bone and joint application market in this region. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019, due to large pool of potential reconstructive surgery patients and strong support from federal government. Additionally, companies are expecting large revenue with sufficient market penetration from Asia-Pacific region and thereby focusing on increasing investments in this region. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region.

Major market players having presence in the global regenerative medicine (bone and joint) market include DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler), Orthofix, Inc. (Trinity Evolution) and NuVasive, Inc. (Osteocel Plus).

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

Stem Cell Therapy

Biomaterial

Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

Bone Graft Substitutes

Osteoarticular Diseases

Allogeneic Bones

Autogenic Bones

Others

Regenerative Medicine (Bone and Joint) Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World

Request a Sample of this Report http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

a

Clinical Information Systems Market Insight and Projections

The Johns Hopkins Medicine Institute had conducted a study that showed at least 40 of physicians had exceeded their predicted number of patients in a typical day. The growing number of patients that suffer from various critical diseases has increased the load on hospitals to diagnose and cure a larger number of patients with increased rates of efficiency and accuracy. All these factors have created a need for a sophisticated management system that can handle the complicated clinical data of patients. This creates the basis of the global clinical information systems market.



Browse Full Global Clinical Information Systems Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/clinical-information-systems.html


About the Clinical Information Systems Market



Clinical information systems is actually a computer guided system that stores, manages, and rechecks all medical data in hospitals such as the health history of all patients, doctor’s notes and prescriptions, along with any other special comments. All this data is stored digitally. The clinical information system will gain this information and enable an easier decision making process and deliver a more efficient and effective clinical care delivery. It also helps reduce and eventually replace paper work. The clinical information system also helps through the computerization of self-reciprocating tasks that require high accuracy. It also helps in the automated recording of observations made through medical equipment and lab results. The functions of a clinical information system are not constricted to singular areas that deal with diagnostics management and management of lab data. It is a widespread and incorporates all aspects of clinical information.



Market Drivers and Restraints



When you look at the technological advancements made by the developed countries in the healthcare industry, it becomes clearer that the increasing patient load requires a computerized approach to manage the extra work in both developed as well as developing countries. The market is predicted to show substantial rates of growth over the coming years. The increasing number of state of the art medical facilities on a global level is expected to exponentially increase the demand for clinical information systems. However, this also leads to the prime restraining factor in the clinical information systems market: the increasingly high cost of installation and maintenance that is involved. There is also the requirement of trained professionals that are eligible to handle the systems, which could impede the market’s growth. The healthcare providers in the West are currently largely oriented in clinical information systems. Their current goals are restricted to administrative and financial functions. In time, they are expected to handle directly supporting patients by assisting physicians and other professionals in their regular tasks.



Key Companies



The top players that are involved in the clinical information systems market are Accunture, iMDsoft and Thermo Scientific, Allegro CTMS, Clinicmaster, Quintiles, and Surgical Information Systems LLC. Most of the key names in the clinical information system market are based in the U.S. and Europe. The developing countries are set to show a great scope of growth due to accelerating rates of urbanization.



Areas of Segmentation



The clinical information systems market is generally segmented on the basis of geography. The market consists of four regions: Europe, North America, Asia-Pacific and Rest of the World. The North American and European zones lead the market in terms of revenue generated, followed by Asia-Pacific and Rest of the World respectively.



Another categorization method involves the technology used. The clinical information systems market can be divided into cloud based and web based services. The web based services hold the larger market share, while the cloud based services are considered to be on the higher end of the market.



Another area of categorization includes the hardware and software that are used in this market.



In conclusion, developed countries are showing the greatest promise of growth in the clinical information systems market, while the developing countries are set to show the fastest rate of growth.



Request a Sample of this Reporthttp://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=544





About Us



Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.



TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Healthcare Information System Market Study 2018

The healthcare information technology (HIT) system market is poised for tremendous growth in forecast, 2013 - 2019. Today, Information technology (IT) has emerged as a key solution for the healthcare industry facilitating new improvements in terms of safety, quality, and efficiency of healthcare delivery in a lucrative manner. The overall healthcare delivery model is experiencing an unprecedented advancement which is propelled by different initiatives, financial benefits and enhanced administrative efficiencies - all resulting in the evolution of healthcare information system technology. Several healthcare consulting organizations focus on assisting health providers through changes in healthcare delivery, most of which are empowered by IT services.

Browse Report: http://www.transparencymarketresearch.com/healthcare-information-system.html


Introduction to Healthcare Information System Market
Healthcare information system is a system that manages, stores, and transmits critical clinical information pertaining to the health of patients or work events of a health organization within the healthcare sector. Healthcare information systems are implemented to support the objectives of healthcare effectiveness, quality of care, and administrative deliveries. Due to the existence of IT services, healthcare providers can effortlessly collect, retrieve, store, and transfer their critical medical data electronically with effective point-of-care delivery, within low costs, and minimal time durations.


Healthcare information system market is continually adopting various healthcare IT solutions and with its promising advancements it has gracefully transformed from being paper-based healthcare system into a digitized HCIT market. HCIT provides clinicians the authorization to access patient data, transform files, and make crucial decisions in the best possible manner. These systems have reduced the administrative fuss of wielding patients’ documents and information and streamlined all the processes in the medical field. This, by far, has been the most modest transformation in the healthcare industry in the past decade.


Globally, increase in the geriatric population is playing a crucial role in the demand of healthcare information system market. The aging population has less regenerative abilities and is certainly more susceptible to suffering from sickness, diseases, and syndrome. However, the market also witnesses a handful of various other factors that have led in the growth of the HCIT market. The consecutive paragraph confers the key market drivers, as well as inhibitors performing in this market.


Market Drivers and Inhibitors
Some of the additional key driving factors identified by this market are rising healthcare cost, growing need for integrated healthcare systems, government initiatives including, (pay-for-performance (P4P) program, e-health, health connect, etc.), rise in chronic disorders, financial support from the U.S. government, and increasing investments by healthcare IT players. Moreover, in attempt to reduce medical errors related to maintaining medical documents there has been a rise in the adoption rate of computerized physician order entry (CPOE) that is likely to fuel the growth of this market in the future.
On the contrary, market restraints and risks are substantial. Lack of experienced professionals, interoperability issues, open source software instead of direct software revenues, and high maintenance & service expenses are major disruptors in this market.
Over the last few decades, some technological advances in IT have facilitated enhanced management, gathering, processing, and distribution of data, all achieved by patient consent and monitoring of performance. Also, heavy investments from private and government market players and speedy advancements in the healthcare information system market makes this industry one of the most dynamic industries across the globe.


Regional Analysis
In the segment of geographic analysis, North America is entitled to be the largest healthcare information systems market with a revenue share of 52.1%. This is due to the presence of high healthcare costs and state-of-the-art healthcare infrastructure facilitating the implementation of healthcare information systems in this region.

Successive to North America, Europe accounted to be the next highly grossing market in terms of market share in 2012. It was valued at $11.0 billion in 2012. Additionally, the Asia Pacific healthcare IT market is estimated to increase at the fastest CAGR of 17% in the forecast period. Some of the other rapidly growing markets for healthcare information systems are India, China, Japan, Russia, and the U.S.

Nevertheless, the global healthcare information system market, already substantial, was valued at $35.1 billion and is expected to grow at a CAGR of 7.1% in the forecast, 2013 to 2019. By 2019 estimates suggest that it will reach an estimated value of $53.2 billion.


Request a Sample of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1457


About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Laboratory Information Systems Market is Expected to Reach USD 2.1 Billion Globally in 2019

According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) “Laboratory Information System Market (Application Based- Clinical Diagnostics LIS and Drug Delivery LIS; Delivery Based- Web Based Technology, On-premise Technology and Cloud Based Technology; Component Based- Hardware, Software and Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the global Laboratory Information System market was valued at USD 1,381.4 billion in 2013 and is expected to grow at a CAGR of 7.7% from 2013 to 2019, to reach an estimated value of USD 2,158.0 billion in 2019.

Enquiry Before Buying:http://www.transparencymarketresearch.com/laboratory-information-systems.html

Globally, improvement in healthcare services is playing a major role in increasing the demand for laboratory information system. As a result, this market is expected to grow at a CAGR of about 7.7% during 2013 – 2019.

Some of the key driving factors for the laboratory information system market are increasing need for integrated healthcare information systems, rising government initiatives and rising investments by healthcare IT players. However, the market faces some restraints such as lack of experienced professionals, high maintenance and service expenses and interoperability issues. The laboratory information system market is also witnessing the use of mobile phones. Also, companies are focusing on new product launches.


North America has the largest laboratory information system market and Europe is the fastest growing laboratory information system market. Some of the fastest growing markets for laboratory information system market are Japan, Germany, U.S. and U.K.. Emerging markets, which hold huge potential and increasing demand for powerful IT systems in diagnostic and medical laboratories are some of the major opportunities for the laboratory information systems market.

Clinical diagnostics laboratory information system has the largest market share on the basis of its applications and is expected to grow at a CAGR of about 8.9% during 2013 – 2019. On the basis of its mode of delivery, the market can be classified into web based technology, on-premise technology and cloud based technology market for laboratory information systems.

McKesson Corporation is the leading player in the laboratory information systems market. Other major players of laboratory information systems market include Merge Healthcare Incorporated, Cerner Corporation and others.

Browse the full report at http://www.transparencymarketresearch.com/laboratory-information-systems.html

The global laboratory information system market is segmented as follows:

Laboratory Information System Market, by application mode
Clinical Diagnostics LIS
Drug Delivery LIS
Laboratory Information System Market, by delivery mode
Web based technology
On-premise technology
Cloud based technology
Laboratory Information System Market, by components
Software
Hardware
Services
Laboratory Information System Market, by geography
North America
US
ROW
Asia
Japan
China
Europe
UK
Germany
France
Rest of the World (RoW)

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1482


About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Global market of E-Prescribing is expected to reach USD 887.8 million in 2019

According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) “E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Enquiry Before Buying : http://www.transparencymarketresearch.com/e-prescribing-market.html

The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors. The E-Prescribing system is used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are some of the key driving factors for the E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system. Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

On the other hand, high cost of E-Prescribing system and lack of patient privacy and security impede the growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe is the largest market for E-Prescribing system. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.

Henry Schein, Inc. and Cerner Corporation are the leading player in the global E-Prescribing market. Other major players of E-Prescribing market include athenahealth, Inc., DrFirst, eClinicalWorks, HealthFusion, Inc., and Practice Fusion, Inc.

Browse the full report at http://www.transparencymarketresearch.com/e-prescribing-market.html

The global market of E-Prescribing is segmented as follows:

E-Prescribing Market, By Product Type
Integrated system
Stand-alone system
E-Prescribing Market, By Component
Software
Hardware
Services
E-Prescribing Market, By Delivery Mode
Web-based
On-premise/licensed
Cloud-based
E-Prescribing Market, By Usage Mode
Hand-held device
PC-based
E-Prescribing Market, By End User
Hospital
Office-based physician
E-Prescribing Market, by Geography
Europe
Germany
The U.K.
France
The Netherlands
North America
The U.S.
Canada
Asia
Japan
China
Rest of the World (RoW)

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=929

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.


Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Bioinformatics Market Expected to Reach USD 30.8 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Bioinformatics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, the global bioinformatics market was valued at USD 10.0 billion in 2013 and is expected to grow at a CAGR of 15.5% from 2014 to 2020, to reach an estimated value of USD 30.8 billion in 2020.

Information technology has experienced tremendous growth in the last decade. Perpetually advancing information technology coupled with rising demand for improved healthcare solutions is driving the growth of the global bioinformatics market. Bioinformatics provide benefits namely, increased accuracy, reduced errors, automation of data processing, and reduced turnaround time (TAT). In addition, due to increasing research and development activities in biotechnology, bioscience, pharmaceutical, and life sciences field, adoption of bioinformatics has grown tremendously since last decade. Lack of skilled labor for effective operation of bioinformatics platforms and tools is one of the major factors limiting the growth of the global bioinformatics market. As a result, demand for bioinformatics services is expected to rise during the forecast period.

global-bioinformatics-market
The global bioinformatics market is segmented on the basis of type of platforms, tools and services. Platforms market is further segmented into sequence manipulation platforms, sequence alignment platforms, structural analysis platforms and sequence analysis platforms. Of these, sequence alignment platform segment accounted for the largest share i.e. over 30% in 2013. The dominance of this market segment was mainly due to reduction in overall time for processing data, motif finding, phylogenetic analysis and identification of sequence similarity. Focusing on lack of skilled personnel to operate platforms and tools, market players are now offering services to process data.


Further, global bioinformatics market is segmented as applications namely, preventive medicine, molecular medicine, gene therapy, drug development and others. Molecular medicines include application of bioinformatics in pharamcogenomics, metabolomics, and pharmacoprotemics. Major companies are investing on research involving pharamcogenomics, metabolomics, and pharmacoprotemics. Thus, molecular medicine application segment is currently leading the overall bioinformatics market. Whereas, increasing investments on drug discovery and development, and rising application of bioinformatics propels the growth of drug development application segment. Thus, owing to the mentioned factors the drug development application segment is expected to grow at highest CAGR (%) during the forecast period from 2014 to 2020.

In 2013, North America accounted for the largest market share of over 35% in the global bioinformatics market. Availability of advanced technology and skilled personnel coupled with high adoption rate of bioinformatics in practice are some of the factors that are driving the growth of bioinformatics market in North America. The Asia-Pacific region is expected to grow at the highest CAGR owing to rapidly developing biotechnology industry on the grounds of swiftly rising biotechnology research and development activities coupled with government support to boost biotechnology sector in the region. Some of the key market players contributing to bioinformatics industry include Affymetrix, Inc., Accelrys, Inc., Agilent Technologies, Inc., and GenoLogics Life Sciences Software.

Browse the full Bioinformatics Market (By Platforms, Tools and Services and By Applications: Preventive Medicine, Molecular Medicine, Gene Therapy Drug Development and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 report at http://www.transparencymarketresearch.com/bioinformatics-market.html


The global bioinformatics market is segmented as follows:
Bioinformatics Market, by Platforms, Tools, and Services
Platforms
Sequence Manipulation Platforms
Sequence Alignment Platforms
Structural Analysis Platforms
Sequence Analysis Platforms
Tools
General Knowledge Management Tools
Specialized Knowledge Management Tools
Services
Data analysis
Sequencing services
Database & management
Other services
Bioinformatics Market, by Applications
Preventive medicine
Molecular medicine
Gene therapy
Drug development
Others
Bioinformatics Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=656


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.